Literature DB >> 1432382

Synthesis of psoralens and analogues.

E Bisagni1.   

Abstract

This review presents briefly the various classical syntheses of psoralens and angelicins which generally start from preformed suitably substituted coumarin or benzofuran derivatives. However, the discovery of the photocyclo-C-4 addition of psoralens to pyrimidine bases prompted new developments in this area. In particular, improved synthesis of psoralens and substituted angelicins, and synthesis of new analogues such as furochromenes, pyridopsoralens, pyrano benzopyrandiones, dioxinocoumarins and aza-psoralens were described recently. This review focuses on the chemical syntheses of these various compounds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432382     DOI: 10.1016/1011-1344(92)85081-5

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  4 in total

1.  Phototoxicity of 7-oxycoumarins with keratinocytes in culture.

Authors:  Christophe Guillon; Yi-Hua Jan; Diane E Heck; Thomas M Mariano; Robert D Rapp; Michele Jetter; Keith Kardos; Marilyn Whittemore; Eric Akyea; Ivan Jabin; Jeffrey D Laskin; Ned D Heindel
Journal:  Bioorg Chem       Date:  2019-05-25       Impact factor: 5.275

2.  SYNTHESIS AND EVALUATION OF WATER-SOLUBLE DIMETHYLAMINOETHYL ETHERS OF METHOXSALEN FOR PROLIFERATIVE SKIN DISORDERS.

Authors:  Christophe D Guillon; Yi-Hua Jan; Natalie Foster; Mridula Choudhuri; Jaya Saxena; Thomas M Mariano; Diane E Heck; Jeffrey D Laskin; Ned D Heindel
Journal:  Heterocycl Lett       Date:  2018 Aug-Oct

Review 3.  Psoralen Derivatives: Recent Advances of Synthetic Strategy and Pharmacological Properties.

Authors:  Joazaizulfazli Jamalis; Faten Syahira Mohamed Yusof; Subhash Chander; Roswanira Abd Wahab; Deepak P Bhagwat; Murugesan Sankaranarayanan; Faisal Almalki; Taibi Ben Hadda
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020

4.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.